FDA 510(k)

BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)

Número K: K251713 · 2025-08-08

Data da decisão2025-08-08

Código do produtoLON

Comité consultivoMI

DecisãoSubstantially Equivalent

Resumo do dispositivo

BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2025-08-08 under 510(k) number K251713. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)?

BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) is a medical device that received FDA 510(k) clearance on 2025-08-08. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K251713.

When did BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) receive FDA 510(k) clearance?

BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) received FDA 510(k) clearance on 2025-08-08, under 510(k) number K251713.

Who is the listed applicant for BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)?

The FDA product code for BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) is LON.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Becton, Dickinson and Company como candidato(a)

K262163BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth K260128BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection Tube K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder K260184Onclarity™ Self-Collection Kit K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes

Ver todos os 102 dispositivos →

Dispositivos Relacionados (Código: LON)

K260282VITEK 2 AST-Streptococcus Inducible Clindamycin ResistancebioMerieux, Inc.K260281VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)BIOMERIEUX K251579VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)bioMerieux, Inc.K250447BD Phoenix™ Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL)Becton, Dickinson and Company K234012VITEK COMPACT PRObioMerieux, Inc.K250344BD Phoenix™ Automated Microbiology SystemBecton, Dickinson and Company

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.